Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | No references |
Homo sapiens | regulator of G-protein signaling 4 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0286 | 0.581 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.02 | 0.3652 | 0.2566 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1461 | 0.4 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.02 | 0.3652 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1461 | 0.4 |
Echinococcus granulosus | geminin | 0.0205 | 0.3758 | 0.269 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.02 | 0.3652 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1461 | 0.4 |
Giardia lamblia | Rrm3p helicase | 0.02 | 0.3652 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.02 | 0.3652 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1461 | 0.4 |
Echinococcus granulosus | ATP dependent DNA helicase PIF1 | 0.02 | 0.3652 | 0.2566 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0114 | 0.1461 | 0.1725 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0078 | 0.0554 | 0.0884 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.02 | 0.3652 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.02 | 0.3652 | 1 |
Echinococcus multilocularis | expressed protein | 0.0451 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0114 | 0.1461 | 0.3825 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.02 | 0.3652 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0078 | 0.0554 | 0.0884 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3758 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.02 | 0.3652 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.3758 | 0.269 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1461 | 0.4 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.581 | 0.5094 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0114 | 0.1461 | 1 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0114 | 0.1461 | 0.2456 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3758 | 1 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.02 | 0.3652 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.581 | 0.5094 |
Entamoeba histolytica | hypothetical protein, conserved | 0.02 | 0.3652 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0045 | 0.0019 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.581 | 1 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.02 | 0.3652 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1461 | 0.4 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0045 | 0.0019 |
Schistosoma mansoni | hypothetical protein | 0.02 | 0.3652 | 0.9717 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1461 | 0.4 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.037 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 0.3548 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 18.8876 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ] | ChEMBL. | No reference |
Potency (binding) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.